Facebook Pixel King dollar's reign looks secure, for now | Financial Express Kolkata - newspaper - Lisez cet article sur Magzter.com
Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

King dollar's reign looks secure, for now

Financial Express Kolkata

|

April 17, 2025

LIBERATION DAY is barely a fortnight ago, and the jolt is taking its place in the annals of modern history.

- Bloomberg

Comparisons have been drawn with Richard Nixon's abrupt decision in 1971 to end the system of fixed exchange rates that prevailed for a generation. Diplomats and investors were appalled. The dollar's time as the anchor of world commerce was coming to a close — or so a popular narrative has gone.

Nixon's unilateral action was shocking. His team was rightly accused of arrogance and bullying — as President Donald Trump is now, with the punitive tariffs he imposed this month. Then, as in the past two weeks, it was popular to pronounce the upheaval as presaging the demise of dollar dominance. Certainly, American prestige has taken a hit. The dollar is being pushed lower by traders and US treasuries, a pillar of the postwar financial set-up, have been roiled.

PLUS D'HISTOIRES DE Financial Express Kolkata

Financial Express Kolkata

Corruption, bribe are Stalin’s real friends, alleges Vijay

TVK FOUNDER Vijay on Monday stepped up his attack on Tamil Nadu Chief Minister MK Stalin ahead of the high-stakes Assembly polls, alleging that the DMK president’s real friends were “bribery and corruption,’ and asserted that the upcoming elections were “a war between Vijay and Stalin”.

time to read

1 min

February 24, 2026

Financial Express Kolkata

Bonds rise as US-Iran jitters ease

GOVERNMENT BONDS EDGED higher on Monday as geopolitical jitters ebbed ahead of a third round of US-Iran nuclear talks, though heavy debt supply due this week capped gains.

time to read

1 min

February 24, 2026

Financial Express Kolkata

Telecom tariffs to rise 13-15% in FY27: HSBC

THE AVERAGE REVENUE per user (Arpu) for telecom operators could see a 13-15% lift in FY27, buoyed by headline tariff hikes later in the year, analysts said in a recent report by HSBC.

time to read

1 min

February 24, 2026

Financial Express Kolkata

Clearance gridlock slows India’s pumped storage drive

LOGJAM PERSISTS

time to read

3 mins

February 24, 2026

Financial Express Kolkata

CDSCO: 90% of cough syrup units audited

THE CENTRAL DRUGS Standard Control Organisation (CDSCO) has conducted an audit of almost 90% of cough syrup manufacturers in the country, and it hopes to eliminate the“rot”in cough syrup by next season, a top official said on Monday.

time to read

1 min

February 24, 2026

Financial Express Kolkata

AU SFB denies wrongdoing, shares tank 5%

SHARES OF AU Small Finance Bank fell 7.6% intraday before closing 5.3% lower at ₹974.45 on the BSE on Monday, after the lender clarified that there was no indication of fraud or financial impact following its de-empanelment by the Haryana government on February 18.

time to read

1 min

February 24, 2026

Financial Express Kolkata

WhatsApp tells SC it will comply with NCLAT order

GLOBAL TECH GIANTS Meta Platforms and WhatsApp told the Supreme Court on Monday that they will comply with the NCLAT’s directions for extending the Competition Commission of India’s (CCI) privacy and consent guidelines to advertising-related data.

time to read

1 min

February 24, 2026

Financial Express Kolkata

Govt unveils monetisation drive with ₹16.7L-cr plan

NMP 2.0 AIMS TO UNLOCK VALUE ACROSS 12 SECTORS

time to read

2 mins

February 24, 2026

Financial Express Kolkata

Kotak to get EY’s special jury award

EY INDIA HAS announced the names of nine finalists for its 27th Entrepreneur of the Year (EOY) Awards.

time to read

1 min

February 24, 2026

Financial Express Kolkata

Novo Nordisk's obesity shot trails Lilly rival

NOVO NORDISK'S NEXT-GENERATION obesity drug CagriSema underperformed Eli Lilly’s Zepbound in a head-to-head trial, the Danish drug-maker said on Monday, as it suffered a setback in its fight to regain leadership of the weight loss market.

time to read

1 min

February 24, 2026

Listen

Translate

Share

-
+

Change font size